Navigation Links
Buckfire & Buckfire, P.C. Dangerous Drug Lawyers Now Accepting Michigan Actos Lawsuits

Southfield, MI (PRWEB) June 11, 2013

The dangerous drug legal team at the personal injury law firm of Buckfire & Buckfire, P.C. is now actively accepting Actos lawsuits for those patients allegedly suffering serious injuries after taking the prescribed diabetes drug. The dangerous drug lawyers are accepting all cases that involve patients who have been diagnosed with bladder cancer while taking Actos or within five years of their Actos usage.

Actos, also known as a pioglitazone, is a drug that is prescribed for treatment of diabetes, particularly Type 2 diabetes. However, even though Actos is known to be an effective drug in treating this medical condition, the drug has also been allegedly linked to bladder cancer. In fact, on June 15, 2011 the FDA have warned patients that the drug Actos may be associated with developing bladder cancer. (Click here to view the FDA Drug Safety Communication report on Actos).

Patients allegedly suffering from bladder after taking the drug Actos do have legal rights and may have a possible Actos lawsuit against the drug manufacturer, Takeda Pharmaceutical. These cases seek fair compensation to patients who have been allegedly harmed by the medication that was prescribed to them by their physicians.

“There are strict statute of limitations for filing a Michigan Actos lawsuit. If you miss a deadline your case will be lost forever. It is important when choosing your lawyer for your bladder cancer Actos case that you choose an attorney that has significant experience in dangerous drug cases and representing patients injured or harmed by a dangerous drug. At the law firm of Buckfire & Buckfire, P.C. our Michigan Actos lawyers work directly with other national law firms to win the best settlement for our clients,” says Partner and Attorney Lawrence J. Buckfire.

Patients taking Actos and their physicians should be fully aware of the alleged potential association between Actos and bladder cancer, as well as other side effects of the drug.


Buckfire & Buckfire, P.C. is a family-owned Michigan personal injury law firm representing patients who have been diagnosed with bladder cancer or allegedly suffering from bladder cancer during their Actos diabetes drug usage. Patients harmed do have legal rights and there may be legal ground to pursue a lawsuit. The Michigan Actos lawyers at the award winning law firm offers a free no obligation consultation and has a No Win No Fee guarantee, meaning there are no legal fees or costs until your case is settled or won.

To learn more about the Michigan Actos lawyers at Buckfire & Buckfire, P.C. call toll-free at (800) 606-1717 or visit the law firm website at

To view a recent video by the Buckfire & Buckfire, P.C. law firm on their active representation of Actos lawsuits visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Buckfire & Buckfire, P.C. Accident Attorneys Announce New Ugly Christmas Sweater Social Media Contest
2. Slip and Fall Accident Attorney At Buckfire & Buckfire, P.C. Makes Michigan Lawyers Weekly For Fall on Ice Settlement
3. Buckfire & Buckfire Motorcycle Attorney Meets with Legislators on Issues Affecting Injured Motorcyclists
4. Michigan Car Accident Attorneys at Buckfire & Buckfire, P.C. Sponsor Gala for Spinal Cord Injury Victims
5. Michigan Bike Accident Lawyers at Buckfire & Buckfire Celebrate Bicycle Helmet Safety Week
6. Michigan Car Accident Lawyer at Buckfire & Buckfire, P.C. Creates Drunk Driving Deaths Infographic
7. Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week
8. Buckfire & Buckfire, P.C. Michigan Hip Replacement Lawyers Now Accepting Stryker Hip Implant Lawsuits
9. Buckfire & Buckfire, P.C. Lawyers Now Accepting Michigan Mirena IUD Lawsuits
10. Research shows efficacy of treatment model developed at Women & Infants
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: